BNTX - BioNTech SE

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

Currency in EUR. All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
Total Revenue
110,098
108,589
127,575
61,598
Cost of Revenue
19,998
17,361
13,690
9,318
Gross Profit
90,100
91,228
113,885
52,280
Operating Expense
287,060
272,746
167,738
113,557
Operating Income
-196,960
-181,518
-53,853
-61,277
Net Non Operating Interest Income Expense
2,557
-263
227
1,404
Other Income Expense
-
2,341
5,966
-26,033
Pretax Income
-192,062
-179,440
-47,662
-85,905
Tax Provision
-266
-268
600
45
Net Income Common Stockholders
-191,796
-179,056
-48,019
-85,653
Diluted NI Available to Com Stockholders
-191,796
-179,056
-48,019
-85,653
Basic EPS
-
0
0
0
Diluted EPS
-
0
0
0
Basic Average Shares
-
211,499
226,262
226,262
Diluted Average Shares
-
211,499
226,262
226,262
Total Operating Income as Reported
-196,960
-181,518
-53,854
-61,277
Rent Expense Supplemental
1,638
1,715
-
1,611
Total Expenses
307,058
290,107
181,428
122,875
Net Income from Continuing & Discontinued Operation
-191,796
-179,056
-48,019
-85,653
Normalized Income
-191,796
-181,394
-52,254
-67,430
Interest Income
4,620
1,781
1,996
2,133
Interest Expense
1,708
1,718
1,721
676
Net Interest Income
2,557
-263
227
1,404
EBIT
-190,354
-177,722
-45,941
-85,229
EBITDA
-155,050
-
-
-
Reconciled Cost of Revenue
19,998
17,361
13,690
9,318
Reconciled Depreciation
35,304
33,896
21,984
10,529
Net Income from Continuing Operation Net Minority Interest
-191,796
-179,056
-48,019
-85,653
Total Unusual Items Excluding Goodwill
-
2,341
6,050
-25,955
Total Unusual Items
-
2,341
6,050
-25,955
Normalized EBITDA
-155,050
-146,167
-30,007
-48,745
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
3.4964
1,815
-7,732